Validation cohort (N = 286)
Multivariate
Variable	HR (95% CI)	P	adj. P
RHCG(cont.)	1.55 (1.23 - 1.94)	<0.001	0.001
Tumor stage (pT2 vs. pT3-4)	2.03 (1.31 - 3.14)	0.001	0.001
Gleason score (<7 vs. ≥7)	2.90 (1.71 - 4.92)	<0.001	<0.001
Pre-op. PSA (<10 vs. ≥10)	1.74 (1.13 - 2.67)	0.011	0.011